We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| China Medical | CMSH | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 52.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 52.00 | 52.00 |
| Top Posts |
|---|
Posted at 27/9/2010 11:55 by dasv assuming I've got the symbol for CMSH in HK right (867) the new thread will be here:- |
Posted at 24/9/2010 17:31 by dasv droid.Yes I am still in. h-l transferred my shares to my new TDW sipp this week before the deadline. they pulled their finger out to do this as myother holdings have not gone across yet. I also have CMSH shares in my TDW dealing account. I noticed the WCC thread and will be creating a new thread. When it's up I'll put a link in. Isn't the HK float on the 28th? edit: yep:- "Trading of the shares is expected to commence on Tuesday, 28 September 2010 on the Main Board of the HKEx under the stock code 867. Shares will be traded in board lots of 800 shares. " |
Posted at 10/9/2010 14:02 by 2ngawang Sold my UK holding due to lowly priced HK IPO. Probably CMSH wants to ensure a successful debut and had therefore lowered its current share price relative to NAV to achieve and appease HK-ers and to raise funds but it's at a detriment to UK faithfuls.Can buy back in HK. |
Posted at 10/9/2010 13:28 by dasv Stegrego - you can't sell online either with HL.they are not issuing certificates for SIPP holdings. Deadline is 24th Sep with them. They have my account details at TDW. I doubt they'll transfer on time. On the 24th they will be selling all remaining CMSH shares from HL holders so I wouldn't expect a good price that day for selling. Maybe a technical buying opp in the TDW account though. |
Posted at 09/9/2010 16:47 by standtall DJ China Medical Sys. Response to press speculation TIDMCMSH RNS Number : 4560S China Medical System Holdings Ltd 09 September 2010 +------------------- | For Immediate release | 9 September 2010 | +------------------- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATION. China Medical System Holdings Ltd ("CMS" or "the Company") Response to press speculation The Board of China Medical System Holdings Limited (AIM: CMSH) notes the recent press speculation regarding a possible fundraising and confirms that it is conducting a roadshow to certain institutional investors in connection with its proposed listing of the Company's shares on the main board of The Hong Kong Stock Exchange Limited (the "Proposed Listing"). Any offer will be subject to investor demand and market conditions and there is no guarantee that it will proceed. At the EGM, shareholders approved resolutions relating to, among others, cancellation of the admission of the shares of the Company to trading on AIM (the "Delisting") conditional upon the Proposed Listing occurring and on the same day as the date of the Proposed Listing. The resolution approving the Delisting allows the Delisting to occur within a three month period from 20 August to 19 November 2010.It is currently expected that the Proposed Listing will occur on 28 September 2010 (Tuesday). Should there be a change in the expected date of the Proposed Listing and the date of the Delisting, the Company will make an announcement regarding such change as soon as practicable and in any event not later than ten clear business days in advance of the final date of Delisting. For further information, please contact: +------------------- | China Medical System Holdings Ltd | + (852) 2369 3889 | +------------------- | Vincent Hui | | +------------------- | Seymour Pierce Limited (Nominated | + 44 (0)20 | | Adviser) | 7107 8344 | +------------------- | Chris Howard / Catherine Leftley | | +------------------- The information contained in this document is not for release, publication or distribution, directly or indirectly, in whole or in part, in, into or from in the United States of America (including its territories and possessions, any state of the United States and the District of Columbia). These materials do not contain, constitute or form part of an offer to sell or the solicitation of an offer to purchase securities in the United States or in any other jurisdiction. The securities referred to herein (the "Securities") have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States absent registration under the Securities Act except pursuant to an available exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There will be no public offer of the Securities in the United States or in the United Kingdom. This notice does not constitute an offer to subscribe for any securities of the Company. Any investment decision in relation to securities offered pursuant to the Proposed Listing should be taken solely in reliance on the information provided in any applicable offer document the Company may issue. Notes for editors China Medical System Holdings Limited China Medical System Holdings Limited is listed on the Alternative Investment Market (AIM) of the London Stock Exchange with the ticker symbol "CMSH". For further information, please visit www.chinamedicalsyst CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND ESTIMATES This announcement contains certain forward-looking statements and estimates with respect to the financial condition, results of operations and business of the Group and certain plans and objectives of the Board of the Company with respect thereto. These forward-looking statements and estimates can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as 'anticipate', 'target', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'will', 'may', 'should', 'would', 'could' or other words of similar meaning. These statements are based on estimates, assumptions and assessments made by the Board in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe appropriate. By their nature, forward-looking statements and estimates involve risk and uncertainty, because they relate to events and depend on circumstances that will or may occur in the future and the factors described in the context of such forward-looking statements in this announcement could cause actual results and developments to differ materially from those expressed in or implied by such forward-looking statements or estimates. Although the Group and the persons who have accepted responsibility for the information contained in this announcement believe that the expectations reflected in their respective forward-looking statements or estimates are reasonable, they can give no assurance that such expectations will prove to have been correct and the Group and the persons who have accepted responsibility for the information contained in this announcement therefore caution you not to place undue reliance on these forward-looking statements or estimates which speak only as at the date of this announcement. OVERSEAS JURISDICTIONS The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom may be affected by the laws of the relevant jurisdictions in which they are located or of which they are citizens. Such persons (including, without limitation, nominees, trustees and custodians) should inform themselves of, and observe, any applicable legal or regulatory requirements of their jurisdictions. This information is provided by RNS The company news service from the London Stock Exchange SPCDMGGLKLZGGZM (END) Dow Jones Newswires 09-09-10 1544GMT |
Posted at 31/8/2010 18:56 by 2ngawang dasv,will check out the anti-depressant drug. I do know of a Chinese herbal plc in HK which has the largest amount of (organic)antioxidant herbals in its pharmacopia. It is HK:8058 and it's a favourite of some HK analyst. Have a look there. Wonder if CMSH will split its shares and/or raise its HKIPO initial offering price as done by IPO 2233? Ngawang |
Posted at 31/8/2010 12:20 by dasv 2ngawang - check out the half yearly report - - each product marketed is described - CMSH has the rights to market the biggest selling anti-depressant in China. Surely a growth market? ;) |
Posted at 31/8/2010 12:15 by 2ngawang dasv,When I see anything mentioned in the HK Press, I shall post here. As far as I'm aware, there are many Chinese medicine/herbal application shares listed in HK and China where they are popular and believed by the populace to be beneficial. CMSH may be the first of a few(?)which sells Western medicines for ailments best treated by known Western formulae. |
Posted at 28/7/2010 12:08 by penpont I just had a look back at a couple of Equity Dev notes - available here if you register:Although they didn't cover the recent full year results, they do offer some comparative data in the 2009 interim note, suggesting the av PE of similar Chinese medical Cos is 22.8. Assuming that CMSH earns around 2p this year (previous growth suggests to me that is possible) that would indicate a price of around 45p. The volatility in Chinese stocks with HK listing intentions has unfortunately turned out to be pretty ludicrous, leaving small cos like CMSH looking like pure gambling counters. I seem to remember something similar with ACHL and of course WCC has had its ups and downs too. I had always thought that of the Chinese Cos I owned shares in, this was the better in terms of overall quality of earnings and I'm still hopeful that post HK that will demonstrate itself in the share price. An interim TS would perhaps help settle things meantime though. |
Posted at 13/3/2010 13:04 by azalea There are some interesting similarities between CMSH and HCM that might be worth highlighting. Both, are Aim listed China based companies in the pharmaceutical sector, HCM(51.3m shares)is focused on traditional Chinese medicines, whilst CMSH(47.4m)is focused on modern medicines. Both have very large percentage of shares held by a small number of investors.Both have seen their share price double in the last 6 months.HCM full year figures were announced on the 4/3, which despite showing a number of very significant improvements across the board, still resulted in a ptx loss of $5.01m. Nevertheless, the share price has since risen 25% ( 200 to 250p) with the IC(12/3) giving a buy recc. CMSH(2009 Interims -T/O, Ptx and Eps, well up on 2008) reports FY results in April with a consensus forecast of an increase 50% over 2008 and in 2010 a circa 30% on 2009. CMSH is a Forbes 100 top 100 Enterprise company with most potential in 2009. With 700 full time staff, covering 5,400 hospitals in 280 cities, it is aiming to become the largest pharmaceutical sales and marketing service provider in China and has begun to recruit 300 graduate trainees. Against this background and assuming a fair comparison with HCM, CMSH should see its share price increase conservatively by 25% on/after FY results. DYOR. |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
